
Novo Nordisk's latest weight loss drug deal is with an AI-powered research firm
Novo Nordisk is diving deeper into the AI drug discovery race, making a big bet on the future of weight loss drugs — just as investors might be beginning to question who (and what) is steering the ship. On Wednesday, the Danish pharmaceutical giant …